monthly glp-1 injection Pfizer Phase IIb Data Support Dosing for Obesity Only 12 injections a year?
Description
Because lasting change starts when we treat obesity as a chronic disease, not a choice
Defining the Roles of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Management of Chronic Kidney Disease in Adults with Type 2 Diabetes With or Without Overweight/Obesity: An International Delphi Consensus
The clinical trial NCT07092605 is underway but results are not yet available
Serious risks associated with using Quinine to prevent or treat nocturnal leg cramps
Authors: Zheng SL, Roddick AJ, Aghar-Jaffar R, Shun-Shin MJ, Francis D, Oliver N, Meeran K
